VDR and systemic sclerosis: Paradoxically, comparative analyses reveal no significant differences in these inflammatory biomarkers between SSc patients and healthy controls, suggesting that VDR downregulation may reflect a secondary phenomenon rather than a primary driver of SSc pathogenesis (Jacquerie et al. 2021; Zerr et al. 2015).